SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024989
Filing Date
2021-05-06
Accepted
2021-05-06 16:16:52
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20210331.htm   iXBRL 10-Q 1925519
2 EX-10.4 kura-ex104_249.htm EX-10.4 102481
3 EX-10.5 kura-ex105_250.htm EX-10.5 98017
4 EX-10.6 kura-ex106_252.htm EX-10.6 109533
5 EX-10.7 kura-ex107_251.htm EX-10.7 113254
6 EX-10.8 kura-ex108_253.htm EX-10.8 20932
7 EX-31.1 kura-ex311_6.htm EX-31.1 17441
8 EX-31.2 kura-ex312_9.htm EX-31.2 17274
9 EX-32.1 kura-ex321_8.htm EX-32.1 9539
  Complete submission text file 0001564590-21-024989.txt   6325291

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA kura-20210331.xsd EX-101.SCH 31322
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20210331_cal.xml EX-101.CAL 43199
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20210331_def.xml EX-101.DEF 69926
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20210331_lab.xml EX-101.LAB 243110
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20210331_pre.xml EX-101.PRE 172810
15 EXTRACTED XBRL INSTANCE DOCUMENT kura-10q_20210331_htm.xml XML 1079400
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 21898013
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences